30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Emisphere Technologies Inc (EMIS)

Track

Stock chart
Ticker: EMIS Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Garone Michael
Secretary, CFO
1 purchase — total 64,800 USD
Buy 17 Sep 2010
Value US$1,627,181.25 | Price 71.79 | Shares 35,834
Buy 15 Sep 2010
Value US$3,351,570.13 | Price 458.96 | Shares 33,643
Buy 15 Sep 2010
Value US$3,143,034.49 | Price 181.75 | Shares 38,072
Buy 15 Sep 2010
Value US$2,700.00 | Price 1.08 | Shares 2,500
Buy 15 Sep 2010
Value US$35,200.00 | Price 1.10 | Shares 32,000
Sale 9 Dec 2009
Value US$4,900.00 | Price 0.70 | Shares 7,000
Sale 9 Dec 2009
Value US$3,500.00 | Price 0.70 | Shares 5,000
Sale 9 Dec 2009
Value US$3,525.00 | Price 0.71 | Shares 5,000
Sale 9 Dec 2009
Value US$3,600.00 | Price 0.72 | Shares 5,000
Sale 9 Dec 2009
Value US$5,550.00 | Price 0.74 | Shares 7,500
Buy 19 Aug 2008
Value US$61,924.80 | Price 4.20 | Shares 14,744
Buy 19 Aug 2008
Value US$838.00 | Price 4.19 | Shares 200
Buy 19 Aug 2008
Value US$418.50 | Price 4.19 | Shares 100
Buy 19 Aug 2008
Value US$418.00 | Price 4.18 | Shares 100
Buy 19 Aug 2008
Value US$3,073.29 | Price 4.17 | Shares 737
Buy 19 Aug 2008
Value US$2,080.00 | Price 4.16 | Shares 500
Buy 19 Aug 2008
Value US$24,900.00 | Price 4.15 | Shares 6,000
Buy 19 Aug 2008
Value US$18,216.00 | Price 4.14 | Shares 4,400
Buy 19 Aug 2008
Value US$1,239.00 | Price 4.13 | Shares 300
Buy 19 Aug 2008
Value US$411.00 | Price 4.11 | Shares 100
Buy 19 Aug 2008
Value US$1,640.00 | Price 4.10 | Shares 400
Buy 19 Aug 2008
Value US$1,304.71 | Price 4.09 | Shares 319
Buy 19 Aug 2008
Value US$816.00 | Price 4.08 | Shares 200
Buy 19 Aug 2008
Value US$1,221.00 | Price 4.07 | Shares 300
Buy 19 Aug 2008
Value US$6,496.00 | Price 4.06 | Shares 1,600
Buy 18 Aug 2008
Value US$74,680.20 | Price 4.20 | Shares 17,781
Buy 18 Aug 2008
Value US$3,012.61 | Price 4.19 | Shares 719
Buy 18 Aug 2008
Value US$4,598.00 | Price 4.18 | Shares 1,100
Buy 18 Aug 2008
Value US$1,668.00 | Price 4.17 | Shares 400
Buy 9 May 2008
Value US$2,197.00 | Price 1.69 | Shares 1,300
Buy 9 May 2008
Value US$6,552.00 | Price 1.68 | Shares 3,900
Buy 9 May 2008
Value US$7,755.00 | Price 1.65 | Shares 4,700
Buy 9 May 2008
Value US$3,520.00 | Price 1.60 | Shares 2,200
Buy 9 May 2008
Value US$3,148.60 | Price 1.60 | Shares 1,968
Buy 9 May 2008
Value US$1,272.00 | Price 1.59 | Shares 800
Buy 9 May 2008
Value US$208.56 | Price 1.58 | Shares 132
Buy 31 Dec 2007
Value US$13,336.00 | Price 2.67 | Shares 5,000
Buy 22 Aug 2007
Value US$0.00 | Price 0.00 | Shares 99,246
Buy 22 Aug 2007
Value US$0.00 | Price 0.00 | Shares 129,390
Buy 9 May 2006
Value US$3,911,746.02 | Price 8.26 | Shares 473,577
Buy 9 May 2006
Value US$1,552,706.54 | Price 8.26 | Shares 187,979
Buy 9 May 2006
Value US$260,636.04 | Price 8.26 | Shares 31,554
Buy 9 May 2006
Value US$2,204,511.40 | Price 8.26 | Shares 266,890
Sale 16 Sep 2004
Value US$1,805.00 | Price 3.61 | Shares 500
Sale 7 May 2004
Value US$25,915.00 | Price 5.18 | Shares 5,000
Sale 7 May 2004
Value US$533.85 | Price 5.18 | Shares 103
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-09-17 2010-09-17 B Purchase Garone Michael

Secretary, CFO

Officer
35,834 +43.6%
71.79
US$1,627,181 		35,834 +43.6% 71.79 US$1,627,181
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
33,643 -11.7%
458.96
US$3,351,570 		33,643 -11.7% 458.96 US$3,351,570
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
38,072 -11.3%
181.75
US$3,143,034 		38,072 -11.3% 181.75 US$3,143,034
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
2,500 +7.8%
1.08
US$2,700 		2,500 +7.8% 1.08 US$2,700
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
32,000 +inf%
1.10
US$35,200 		32,000 +inf% 1.10 US$35,200
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
7,000 -25.5%
0.70
US$4,900 		7,000 -25.5% 0.70 US$4,900
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -15.4%
0.70
US$3,500 		5,000 -15.4% 0.70 US$3,500
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -13.3%
0.71
US$3,525 		5,000 -13.3% 0.71 US$3,525
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -11.8%
0.72
US$3,600 		5,000 -11.8% 0.72 US$3,600
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
7,500 -15.0%
0.74
US$5,550 		7,500 -15.0% 0.74 US$5,550
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
14,744 +41.8%
4.20
US$61,925 		14,744 +41.8% 4.20 US$61,925
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
200 +0.6%
4.19
US$838 		200 +0.6% 4.19 US$838
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.3%
4.19
US$418 		100 +0.3% 4.19 US$418
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.3%
4.18
US$418 		100 +0.3% 4.18 US$418
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
737 +2.2%
4.17
US$3,073 		737 +2.2% 4.17 US$3,073
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
500 +1.5%
4.16
US$2,080 		500 +1.5% 4.16 US$2,080
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
6,000 +21.7%
4.15
US$24,900 		6,000 +21.7% 4.15 US$24,900
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
4,400 +18.9%
4.14
US$18,216 		4,400 +18.9% 4.14 US$18,216
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
300 +1.3%
4.13
US$1,239 		300 +1.3% 4.13 US$1,239
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.4%
4.11
US$411 		100 +0.4% 4.11 US$411
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
400 +1.8%
4.10
US$1,640 		400 +1.8% 4.10 US$1,640
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
319 +1.4%
4.09
US$1,305 		319 +1.4% 4.09 US$1,305
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
200 +0.9%
4.08
US$816 		200 +0.9% 4.08 US$816
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
300 +1.4%
4.07
US$1,221 		300 +1.4% 4.07 US$1,221
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
1,600 +8.0%
4.06
US$6,496 		1,600 +8.0% 4.06 US$6,496
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
17,781 +801.3%
4.20
US$74,680 		17,781 +801.3% 4.20 US$74,680
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
719 +47.9%
4.19
US$3,013 		719 +47.9% 4.19 US$3,013
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
1,100 +275.0%
4.18
US$4,598 		1,100 +275.0% 4.18 US$4,598
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
400 +inf%
4.17
US$1,668 		400 +inf% 4.17 US$1,668
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
1,300 +3.4%
1.69
US$2,197 		1,300 +3.4% 1.69 US$2,197
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
3,900 +11.2%
1.68
US$6,552 		3,900 +11.2% 1.68 US$6,552
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
4,700 +15.6%
1.65
US$7,755 		4,700 +15.6% 1.65 US$7,755
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
2,200 +7.9%
1.60
US$3,520 		2,200 +7.9% 1.60 US$3,520
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
1,968 +7.6%
1.60
US$3,149 		1,968 +7.6% 1.60 US$3,149
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
800 +3.2%
1.59
US$1,272 		800 +3.2% 1.59 US$1,272
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
132 +0.5%
1.58
US$209 		132 +0.5% 1.58 US$209
2007-12-31 2007-12-31 B Purchase Novinski Michael V

President and CEO

Officer
5,000 +25.0%
2.67
US$13,336 		5,000 +25.0% 2.67 US$13,336
2007-08-31 2007-08-22 B Purchase GOLDBERG MICHAEL M Non-Executive Director
99,246
0.00
US$0 		99,246 0.00 US$0
2007-08-24 2007-08-22 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
129,390
0.00
US$0 		129,390 0.00 US$0
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
473,577 +inf%
8.26
US$3,911,746 		473,577 +inf% 8.26 US$3,911,746
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
187,979 +inf%
8.26
US$1,552,707 		187,979 +inf% 8.26 US$1,552,707
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
31,554 +8.0%
8.26
US$260,636 		31,554 +8.0% 8.26 US$260,636
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
266,890 +9.3%
8.26
US$2,204,511 		266,890 +9.3% 8.26 US$2,204,511
2004-09-21 2004-09-16 S Sale BLACK MICHAEL E Non-Executive Director
500 -20.6%
3.61
US$1,805 		500 -20.6% 3.61 US$1,805
2004-05-11 2004-05-07 S Sale
BENDER LEWIS H

Sr. VP Business Development
5,000 -26.4%
5.18
US$25,915 		5,000 -26.4% 5.18 US$25,915
2004-05-11 2004-05-07 S Sale
BENDER LEWIS H

Sr. VP Business Development
103 -0.7%
5.18
US$534 		103 -0.7% 5.18 US$534
Explore more

More insider trading research around Emisphere Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America